Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nimotuzumab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07535567
What this trial is testing

Postoperative Radiotherapy With Nimotuzumab ± Benmelstobart in Intermediate-Risk Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 386
Testing effectiveness (Phase 2)Ended earlyNCT00983047
What this trial is testing

Nimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung Cancer

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Biotech Pharmaceutical Co., Ltd. 30
Testing effectiveness (Phase 2)UnknownNCT05803915
What this trial is testing

Neoadjuvant Toripalimab Plus Nimotuzumab in Oral Squamous Cell Carcinoma Prior to Radical Therapy

Who this might be right for
Oral Squamous Cell Carcinoma
Peking Union Medical College Hospital 57
Large-scale testing (Phase 3)Study completedNCT06781073
What this trial is testing

Nimotuzumab in Combined With Chemotherapy for Treatment of IVB Stage,Rrecurrent or Persistent Cervical Carcinoma

Who this might be right for
Cervical Squamous Cell CarcinomaPersistent
Biotech Pharmaceutical Co., Ltd. 118
Testing effectiveness (Phase 2)Looking for participantsNCT06912711
What this trial is testing

TN Induction and Adjuvant Therapy for Resectable Local Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 70
Large-scale testing (Phase 3)Looking for participantsNCT07445048
What this trial is testing

Postoperative Radiotherapy Combined With Nimotuzumab Followed by Benmelstobart in High-Risk Patients With Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head & Neck Squamous Cell CarcinomaHead & Neck CancerPostoperative Adjuvant Treatment
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 370
Testing effectiveness (Phase 2)UnknownNCT06413017
What this trial is testing

Nimotuzumab Combined With ICIs for the Treatment of Advanced Liver Cancer After First Line Treatment Failure

Who this might be right for
HCC
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)UnknownNCT03766178
What this trial is testing

Study of Anti-PD-1 Antibody SHR-1210 Plus Nimotuzumab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 45
Large-scale testing (Phase 3)Study completedNCT00753246
What this trial is testing

Nimotuzumab in Adults With Glioblastoma Multiforma

Who this might be right for
Adults With Glioblastoma Multiforma
Oncoscience AG 150
Testing effectiveness (Phase 2)UnknownNCT00972465
What this trial is testing

Study of Nimotuzumab to Treat Colorectal Cancer

Who this might be right for
Advanced Colorectal Cancer
Peking University 48
Large-scale testing (Phase 3)Study completedNCT02012062
What this trial is testing

Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPC

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 160
Testing effectiveness (Phase 2)Study completedNCT00702481
What this trial is testing

Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Centre, Singapore 32
Testing effectiveness (Phase 2)UnknownNCT01688700
What this trial is testing

Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma Resectable
Zhejiang Cancer Hospital 60
Testing effectiveness (Phase 2)UnknownNCT04367909
What this trial is testing

TC(Docetaxel and Carboplatin) Regimen With or Without Nimotuzumab in Recurrent Metastatic Oral Squamous Cell Carcinoma

Who this might be right for
Oral Squamous Cell Carcinoma
Xin-Hua Xu 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT06773130
What this trial is testing

HRS-4642 Combined With Nimotuzumab in the Treatment of Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
West China Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06722911
What this trial is testing

Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Resectable
Zhejiang Provincial People's Hospital 57
Testing effectiveness (Phase 2)UnknownNCT01232374
What this trial is testing

Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma
Biotech Pharmaceutical Co., Ltd. 144
Testing effectiveness (Phase 2)Active Not RecruitingNCT06429904
What this trial is testing

Nimotuzumab Plus NALIRIFOX in Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Cancer
Peking Union Medical College Hospital 31
Testing effectiveness (Phase 2)Study completedNCT01463605
What this trial is testing

Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical Trial

Who this might be right for
Esophageal Cancer
Chinese Academy of Medical Sciences 46
Testing effectiveness (Phase 2)Looking for participantsNCT06389760
What this trial is testing

Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 57
Next Page